Summary of Significant Accounting Policies - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares	Jun. 30, 2024 USD ($) $ / shares	Mar. 31, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) agreement $ / shares shares	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($) $ / shares	Mar. 31, 2023 USD ($) $ / shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) agreement $ / shares shares	Dec. 31, 2022 USD ($) $ / shares
Concentration Risk [Line Items]
Cost of revenue	$ 78,842	$ 81,920	$ 78,328	$ 75,582	$ 77,612	$ 73,247	$ 69,989	$ 74,539	$ 314,672	$ 295,387	$ 211,927
Sales and marketing	19,405	15,258	17,997	18,910	17,395	16,990	14,332	16,338	71,570	65,055	81,022
Research and development	$ 40,310	$ 36,278	$ 32,984	$ 32,927	$ 29,976	$ 31,734	$ 37,702	$ 37,505	$ 142,499	$ 136,917	$ 143,885
Basic net income per share attributable to common stockholders (in dollars per share) | $ / shares	$ 0.20	$ 0.36	$ 0.21	$ 0.16	$ 0.18	$ 0.22	$ 0.01	$ (0.17)	$ 0.92	$ 0.22	$ (0.28)
Diluted net income per share attributable to common stockholders (in dollars per share) | $ / shares	$ 0.19	$ 0.33	$ 0.20	$ 0.15	$ 0.17	$ 0.20	$ 0.01	$ (0.17)	$ 0.89	$ 0.20	$ (0.28)
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current, Other long-term liabilities				Other Liabilities, Current, Other long-term liabilities				Other Liabilities, Current, Other long-term liabilities	Other Liabilities, Current, Other long-term liabilities
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current								Other Liabilities, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities				Other long-term liabilities				Other long-term liabilities	Other long-term liabilities
Number of separate sublease agreements | agreement					2					2
Impairment of certain long-lived assets									$ 356	$ 1,140	$ 1,635
Impairment loss									356	1,140	163
Goodwill	$ 348,674				$ 348,322				348,674	348,322	315,168
Intangible assets with indefinite lives	44,822				44,821				44,822	44,821
Intangible assets with definite lives	$ 72,896				$ 95,330				72,896	95,330
Advertising expense									$ 9,958	$ 7,857	19,914
Dividend yield									0.00%
Preferred stock, shares authorized (in shares) | shares	10,000,000				10,000,000				10,000,000	10,000,000
Right-Of-Use Asset
Concentration Risk [Line Items]
Impairment of certain long-lived assets											1,472
Property, Plant and Equipment
Concentration Risk [Line Items]
Basic net income per share attributable to common stockholders (in dollars per share) | $ / shares									$ 0.09
Diluted net income per share attributable to common stockholders (in dollars per share) | $ / shares									$ 0.09
Impairment of certain long-lived assets									$ 815	$ 0	$ 0
Minimum
Concentration Risk [Line Items]
Finance lease, term	1 year								1 year
Minimum | JournalDev IT
Concentration Risk [Line Items]
Useful life	3 years								3 years
Maximum
Concentration Risk [Line Items]
Finance lease, term	5 years								5 years
Maximum | JournalDev IT
Concentration Risk [Line Items]
Useful life	10 years								10 years
Revision of Prior Period, Adjustment | Reclassification from sales and marketing to cost of revenue
Concentration Risk [Line Items]
Cost of revenue									$ 7,972
Sales and marketing									(7,972)
Revision of Prior Period, Adjustment | Reclassification from research and development to cost of revenue
Concentration Risk [Line Items]
Cost of revenue									3,448
Research and development									$ (3,448)